Did Debbie Schultz buy Keryx Biopharmaceuticals stock?

Common questions

Did Debbie Schultz buy Keryx Biopharmaceuticals stock?

Yes. Debbie Schultz disclosed 3 purchases of Keryx Biopharmaceuticals (KERX) stock between Apr 27, 2016 and Feb 10, 2017, in STOCK Act reports. Added together, the disclosed ranges come to $3K-$45K.

How big were Debbie Schultz's Keryx Biopharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $3K-$45K.

Did Debbie Schultz make these Keryx Biopharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Debbie Schultz still own Keryx Biopharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Debbie Schultz report these trades?

The latest filing is dated Feb 15, 2017. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.